Hamza Suria, President, CEO at ANAPTYSBIO INC (ANAB), sold 126,172 shares at $70.57 ($9.0M) on 2018-12-10, disclosed to the SEC on 2018-12-12.
Open-market sale of $9.0M ANAB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.57 | 15,276 | $1.1M | 12.0% |
| 2 | $70.57 | 15,276 | $1.1M | 12.0% |
| 3 | $71.49 | 10,347 | $740K | 8.2% |
| 4 | $71.49 | 10,347 | $740K | 8.2% |
| 5 | $72.48 | 4,964 | $360K | 4.0% |
| 6 | $72.48 | 4,964 |
| $360K |
| 4.0% |
| 7 | $70.83 | 4,998 | $354K | 3.9% |
| 8 | $71.11 | 12,003 | $853K | 9.5% |
| 9 | $71.11 | 12,003 | $854K | 9.5% |
| 10 | $71.92 | 9,673 | $696K | 7.7% |
| 11 | $71.92 | 9,673 | $696K | 7.7% |
| 12 | $72.88 | 8,324 | $607K | 6.7% |
| 13 | $72.88 | 8,324 | $607K | 6.7% |
| Total | $71.50 avg | 126,172 | $9.0M | 100% |
| Filing → |
| ANAB | SELL | 2021-11-02 | $2.4M | — | Filing → |
| ANAB | SELL | 2021-10-28 | $480K | — | Filing → |
| ANAB | SELL | 2019-06-12 | $2.8M | — | Filing → |